Prospective Evaluation of Hematological Indices in Prognostication of COVID-19 Infection in Pregnant Population
Journal of SAFOG
; 14(4):356-360, 2022.
Article
in English
| EMBASE | ID: covidwho-2010442
ABSTRACT
Background:
Neutrophil-to-lymphocyte ratio (NLR) is a well-established inflammatory marker that has been studied in COVID-19 inflicted patients. Pregnancy per se is associated with its own physiological changes in hematological parameters. No study has specifically been done on the pregnant population to evaluate the role of various hematological markers for prognosticating the severity of COVID-19 infection.Aim:
The aim of this study was to prospectively evaluate changes in NLR and other indices in a cohort of pregnant women with severe and non-severe COVID-19. Materials andmethods:
Prospective cohort study at a COVID dedicated tertiary care center of a low-middle income country for a period of 6 months involving hospitalized COVID-19 positive pregnant women.Results:
In total, 8/8 (100%) and 6/8 (75%) of the pregnant women with severe COVID-19, had a raised NLR and platelet-to-lymphocyte ratio (PLR), respectively, compared to only 3/47 (6.4%) and 1/47 (2.13%) with non-severe COVID-19 (p <0.0001, p <0.0001). These ratios were noted to normalize at 2 and 4 weeks follow-up in the survivors of severe COVID-19.Conclusion:
This is the first prospective study demonstrating an association between COVID-19 disease severity in pregnant women and NLR and PLR on admission. These indices may be utilized for prognostication and better preparations for the care of pregnant women hospitalized with COVID-19 infections.
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Experimental Studies
/
Observational study
/
Prognostic study
Language:
English
Journal:
Journal of SAFOG
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS